Treace Medical Concepts (TMCI) said Friday its interim data from clinical trials of lapiplasty and adductoplasty to treat bunions and related mid-foot deformities showed low recurrence and continued improvement in pain.
Clinical study data of the two studies of lapiplasty procedure showed a return to protected weight bearing at an average of 7.9 and 8.4 days with recorded pain improvement at 12 months and 48 months.
Data from the study of adductoplasty procedure showed return to protected weight bearing at an average of 7.5 days with recorded pain improvement at 12 months.
The company presented the interim data at the 2025 American College of Foot and Ankle Surgeons Annual Meeting in Phoenix, Arizona.
Price: 8.50, Change: +0.13, Percent Change: +1.55
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.